| UHC Surest Medical and Drug | Occipital Nerve Injections and Ablation (Including Occipital Neuralgia and Headache) - Commercial and Individual Exchange Medical Policy | 2026-01-01 |
| UHC Surest Medical and Drug | Ocrevus® (Ocrelizumab) and Ocrevus Zunovo® (Ocrelizumab and Hyaluronidase-Ocsq) - Commercial Medical Benefit Drug Policy | 2026-01-01 |
| UHC Surest Medical and Drug | Ocular Photoscreening - Commercial and Individual Exchange Medical Policy | 2026-01-01 |
| UHC Surest Medical and Drug | Omnibus Codes - Commercial and Individual Exchange Medical Policy | 2026-01-01 |
| UHC Surest Medical and Drug | Oncology Medication Clinical Coverage - Commercial Medical Benefit Drug Policy | 2026-01-01 |
| UHC Surest Medical and Drug | Orthognathic (Jaw) Surgery - Commercial and Individual Exchange Medical Policy | 2026-01-01 |
| UHC Surest Medical and Drug | Panniculectomy Surgery - Commercial and Individual Exchange Medical Policy | 2026-01-01 |
| UHC Surest Medical and Drug | Percutaneous Neuroablation for Pancreatic Cancer Pain, Severe Cancer Pain, and Trigeminal Neuralgia - Commercial and Individual Exchange Medical Policy | 2026-01-01 |
| UHC Surest Medical and Drug | Percutaneous Patent Foramen Ovale (PFO) Closure - Commercial and Individual Exchange Medical Policy | 2026-01-01 |
| UHC Surest Medical and Drug | Pharmacogenetic Panel Testing - Commercial and Individual Exchange Medical Policy | 2026-01-01 |